Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × Sorafenib × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 115 Liver Neoplasms 36 Leukemia, Myeloid, Acute 30 Carcinoma, Renal Cell 28 Neoplasm Metastasis 24 Breast Neoplasms 22 Carcinoma, Non-Small-Cell Lung 19 Kidney Neoplasms 16 Neoplasms 12 Prostatic Neoplasms 11 Pancreatic Neoplasms 11 Lung Neoplasms 11 Sarcoma 9 Recurrence 9 Myelodysplastic Syndromes 8 Melanoma 8 Colorectal Neoplasms 8 Brain Neoplasms 8 Glioblastoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Leukemia, Myelomonocytic, Chronic 5 Leukemia 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Liver Diseases 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3

Interventions

Surveys and Questionnaires 7 Bevacizumab 5 temsirolimus 4 Standard of Care 4 Sirolimus 4 Interviews as Topic 4 Vorinostat 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olaparib 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1 Temozolomide 1 Sunitinib 1 Sorafenib 1 Rehabilitation 1 Referral and Consultation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡